Skip to main content
. 2021 Aug 4;13(8):e16868. doi: 10.7759/cureus.16868

Figure 2. Overview of effects of SGLT-2 inhibitors leading to cardiorenal protection.

Figure 2

SGLT-2- Sodium-Glucose Co-Transporter 2; AGE- Advanced Glycation End Product; HbA1C- Hemoglobin A1C; eGFR- Estimated Glomerular Filtration Rate